Study points to new drug target in fight against cancer

by Jade Boyd,Rice UniversityWhen oxidized, the protein mitoNEET (green) can close voltage-dependent anion channels, or VDACs (center), passageways that allow metabolites and signaling molecules

Updated on: May 25,2024

Study points to new drug target in fight against cancer

by Jade Boyd,Rice UniversityWhen oxidized, the protein mitoNEET (green) can close voltage-dependent anion channels, or VDACs (center), passageways that allow metabolites and signaling molecules

Updated on:May 25,2024

Oncogenic driver FGFR3-TACC3 requires 5 coiled-coil heptads for activation and disulfide bonds for stability

by Impact Journals LLCFGFR3-TACC3 fusion proteins. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28359FGFR3-TACC3 represents an oncogenic fusion protein frequently identified in gliobl

Updated on: January 30,2024

Oncogenic driver FGFR3-TACC3 requires 5 coiled-coil heptads for activation and disulfide bonds for stability

by Impact Journals LLCFGFR3-TACC3 fusion proteins. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28359FGFR3-TACC3 represents an oncogenic fusion protein frequently identified in gliobl

Updated on:January 30,2024

Drugs to prevent anxiety, stress reactions and inflammation found to reduce risk of metastases after tumor surgery

by Tel Aviv UniversityStress responses and reciprocal stress–cancer interactions. Credit:European Journal of Surgical Oncology(2022). DOI: 10.1016/j.ejso.2022.10.013A short, simple an

Updated on: February 18,2024

Drugs to prevent anxiety, stress reactions and inflammation found to reduce risk of metastases after tumor surgery

by Tel Aviv UniversityStress responses and reciprocal stress–cancer interactions. Credit:European Journal of Surgical Oncology(2022). DOI: 10.1016/j.ejso.2022.10.013A short, simple an

Updated on:February 18,2024

'Hijacker' drives cancer in some patients with high-risk neuroblastoma

by St. Jude Children's Research HospitalThe study authors (from left) Ying Shao, Yu Liu, PhD, and John Easton, PhD. Credit: Seth Dixon / St. Jude Children's Research HospitalResearchers h

Updated on: March 13,2024

'Hijacker' drives cancer in some patients with high-risk neuroblastoma

by St. Jude Children's Research HospitalThe study authors (from left) Ying Shao, Yu Liu, PhD, and John Easton, PhD. Credit: Seth Dixon / St. Jude Children's Research HospitalResearchers h

Updated on:March 13,2024

Infections from a diarrhea-causing parasite are on the rise in the UK, but experts aren't quite sure why

by Paul Hunter,The ConversationLaboratory notifications of Cryptosporidium species in England, Wales and Northern Ireland, by week of specimen, 2023. Credit:Eurosurveillance(2023). D

Updated on: April 20,2024

Infections from a diarrhea-causing parasite are on the rise in the UK, but experts aren't quite sure why

by Paul Hunter,The ConversationLaboratory notifications of Cryptosporidium species in England, Wales and Northern Ireland, by week of specimen, 2023. Credit:Eurosurveillance(2023). D

Updated on:April 20,2024

Markups for oncology services vary at the hospital level

(HealthDay)—There is significant variation in markup of outpatient oncology services across hospitals in the United States, according to a study published online Feb. 17 in theAmerican Journal o

Updated on: April 09,2024

Markups for oncology services vary at the hospital level

(HealthDay)—There is significant variation in markup of outpatient oncology services across hospitals in the United States, according to a study published online Feb. 17 in theAmerican Journal o

Updated on:April 09,2024

Study identifies new test to accurately predict end of life for lung cancer patients

by University of LiverpoolVOCs that increase towards death in the acid dataset. Jitter box plot graph for each metabolite identified as significant from univariate and linear regression analysis.

Updated on: February 01,2024

Study identifies new test to accurately predict end of life for lung cancer patients

by University of LiverpoolVOCs that increase towards death in the acid dataset. Jitter box plot graph for each metabolite identified as significant from univariate and linear regression analysis.

Updated on:February 01,2024

Neoadjuvant endocrine therapy may elicit differential responses in Black and white women with breast cancer

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainBlack women treated with neoadjuvant endocrine therapy for breast cancer were more likely to benefit than white women

Updated on: January 13,2024

Neoadjuvant endocrine therapy may elicit differential responses in Black and white women with breast cancer

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainBlack women treated with neoadjuvant endocrine therapy for breast cancer were more likely to benefit than white women

Updated on:January 13,2024

Study points to racial and social barriers that block treatment for multiple myeloma

by Jennifer DeMoss,UC DavisCredit: Unsplash/CC0 Public DomainA UC Davis Health study reveals persistent racial and social disparities preventing access to autoHCT, a common bone marrow transplan

Updated on: April 28,2024

Study points to racial and social barriers that block treatment for multiple myeloma

by Jennifer DeMoss,UC DavisCredit: Unsplash/CC0 Public DomainA UC Davis Health study reveals persistent racial and social disparities preventing access to autoHCT, a common bone marrow transplan

Updated on:April 28,2024

Final overall study analysis continues to show benefit of sacituzumab govitecan in advanced HR+ breast cancer

byDana-Farber Cancer InstituteOverall survival in the intention-to-treat population. This is the planned final analysis of overall survival in the intent-to-treat population of all randomly assi

Updated on: January 22,2024

Final overall study analysis continues to show benefit of sacituzumab govitecan in advanced HR+ breast cancer

byDana-Farber Cancer InstituteOverall survival in the intention-to-treat population. This is the planned final analysis of overall survival in the intent-to-treat population of all randomly assi

Updated on:January 22,2024

In the lab and in the clinic, alisertib with TAK-228 excels against solid tumors

by CU Anschutz Medical CampusUniversity of Colorado Cancer Center investigator, Jennifer Diamond, MD, and colleagues report promising phase I results of alisertib with TAK-228 against solid tumor

Updated on: April 22,2024

In the lab and in the clinic, alisertib with TAK-228 excels against solid tumors

by CU Anschutz Medical CampusUniversity of Colorado Cancer Center investigator, Jennifer Diamond, MD, and colleagues report promising phase I results of alisertib with TAK-228 against solid tumor

Updated on:April 22,2024

Exploring better care for pregnant women with precancerous cervical cancer

by Medizinische Hochschule HannoverMethylation levels of FAM19A4 (A) and miR124-2 (B) for the different groups of pregnant women. Credit:International Journal of Cancer(2022). DOI: 10.1002

Updated on: January 07,2024

Exploring better care for pregnant women with precancerous cervical cancer

by Medizinische Hochschule HannoverMethylation levels of FAM19A4 (A) and miR124-2 (B) for the different groups of pregnant women. Credit:International Journal of Cancer(2022). DOI: 10.1002

Updated on:January 07,2024